Remove Biosimilars Remove Demo Remove Marketing
article thumbnail

Article EMA Thank You What we expect European regulators to do in December 2023

Agency IQ

Positive *Biosimilar **Generic Notable comment periods closing in December Below are various deadlines regarding E.U. Expected Action Description of action Date Eudamed Module: Market Surveillance [E.U.] Completed development of the EUDAMED Market Surveillance module Q4 2023 Designation of E.U.

article thumbnail

Article EMA Thank You What we expect European regulators to do in June 2024

Agency IQ

and 2 mg [EMA] Product-specific bioequivalence guidance 6/30/2024 Pharmeuropa 36.2